Lipid nanoparticles for engineering next generation CAR T cell immunotherapy
{{output}}
Lipid nanoparticles are a burgeoning technology which has vast potential to improve chimeric antigen receptor (CAR) T cell immunotherapy. This focused review provides an overview of CAR T cell therapy - highlighting its promises, limitations, and challenges - ... ...
